Global Preimplantation Genetic Screening Market Growth (Status and Outlook) 2025-2031

Global Preimplantation Genetic Screening Market Growth (Status and Outlook) 2025-2031

The global Preimplantation Genetic Screening market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

United States market for Preimplantation Genetic Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Preimplantation Genetic Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Preimplantation Genetic Screening is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Preimplantation Genetic Screening players cover Illumina, Inc (US), Thermo Fisher Scientific Inc (US), Agilent Technologies, Inc (US), PerkinElmer, Inc (US), CooperSurgical, Inc (US), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Preimplantation Genetic Screening Industry Forecast” looks at past sales and reviews total world Preimplantation Genetic Screening sales in 2024, providing a comprehensive analysis by region and market sector of projected Preimplantation Genetic Screening sales for 2025 through 2031. With Preimplantation Genetic Screening sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Preimplantation Genetic Screening industry.

This Insight Report provides a comprehensive analysis of the global Preimplantation Genetic Screening landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Preimplantation Genetic Screening portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Preimplantation Genetic Screening market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Preimplantation Genetic Screening and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Preimplantation Genetic Screening.

This report presents a comprehensive overview, market shares, and growth opportunities of Preimplantation Genetic Screening market by product type, application, key players and key regions and countries.

Segmentation by Type:
Next Generation Sequencing (NGS)
Polymerase Chain Reaction (PCR)
Fluorescent In-situ Hybridization (FISH)
Comparative Genomic Hybridization (CGH)
Single Nucleotide Polymorphism (SNP)

Segmentation by Application:
Single Gene Disorders
X-linked Disorders
HLA Typing
Gender Identification

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina, Inc (US)
Thermo Fisher Scientific Inc (US)
Agilent Technologies, Inc (US)
PerkinElmer, Inc (US)
CooperSurgical, Inc (US)
Beijing Genomics Institute (BGI) (China)

Please note: The report will take approximately 2 business days to prepare and deliver.